MedTrace Logo

Efficacy Study of Temperature Controlled Laminar Airflow (TLA)-Treatment in Perennial Allergic Asthma

NCT00986323 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 312

Last updated 2010-11-09

No results posted yet for this study

Summary

The purpose of this study is to determine whether nocturnal environmental control with Temperature controlled Laminar Airflow (TLA) is effective as add on treatment in patients with perennial allergic asthma.

Conditions

Interventions

DEVICE

Temperature controlled Laminar Airflow (TLA)

Nocturnal environmental control with Temperature controlled Laminar Airflow (TLA).

DEVICE

Placebo TLA

Placebo TLA (without filtration and TLA function)

Sponsors & Collaborators

  • Commitum AB

    collaborator INDUSTRY

  • Croel AB

    collaborator INDUSTRY

  • Airsonett AB

    lead INDUSTRY

Principal Investigators

  • Olof Zetterström, MD, PhD. · University Hospital, Linkoeping

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
7 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2010-02-28
Completion
2010-02-28

Countries

  • Denmark
  • Finland
  • Germany
  • Norway
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00986323 on ClinicalTrials.gov